On-Demand: Update on USP 797, 795 and 800

On-Demand: Update on USP 797, 795 and 800

On-Demand: Update on USP 797, 795 and 800

On-Demand: USP 797, 795 and 800

Introduction and Update on USP <797>               

Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health

Upon completion of this activity, pharmacists will be able to: Describe activities that do not fall within the scope of USP 797; Identify key differences between USP<797> of 2008 and USP<797> of 2022; Explain the differences between Category 1, Category 2, and Category 3 Pharmaceutical Compounding Sterile Preparations.

UAN: 0675-0000-24-012-H07-P

 

USP 795 and 800: Critical Regulations and Key Differences

Max Everett, Director of Quality, Olympia Compounding Pharmacy

Upon completion of this activity, pharmacists will be able to: Discuss USP <795> and <800> Regulations; Identify key differences between USP <795> and <800> and use results for program related decisions; Identify the components of a Risk Based Approach and be able to implement a Risk-Based Approach. 

UAN: 0675-0000-24-013-H07-P
 

 

No Comments

Comments are closed.